SCHEMBL30733945

SCHEMBL30733945

O=C(c1ccco1)c1cccc2cccn12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.47
POLB P06746 4/20 0.47
ALDH1A1 P00352 4/20 0.47
MEN1 O00255 2/20 0.47
THRB P10828 1/20 0.47
APEX1 P27695 1/20 0.47
RECQL P46063 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
CES2 O00748 1/20 0.44
CES1 P23141 1/20 0.44
PTPN1 P18031 1/20 0.41
TSHR P16473 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
LMNA P02545 2/20 0.37
ALOX15 P16050 2/20 0.37
HSD17B10 Q99714 2/20 0.37
HPGD P15428 1/20 0.37
MAPT P10636 1/20 0.37
PIM1 P11309 1/20 0.37
CHRNB2 P17787 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6218739 0.89 ALDH1A1 (0.46) KMT2APOLBALDH1A1MEN1THRB
SCHEMBL27001645 0.78 ALDH1A1 (0.42) KMT2APOLBALDH1A1MEN1THRB
SCHEMBL27001659 0.76 ALDH1A1 (0.40) KMT2APOLBALDH1A1MEN1THRB
SCHEMBL27004453 0.76 KMT2A (0.47) KMT2APOLBALDH1A1MEN1THRB
SCHEMBL27004544 0.75 ALDH1A1 (0.40) KMT2APOLBALDH1A1MEN1THRB
SCHEMBL181841 0.72 ALDH1A1 (0.74) KMT2APOLBALDH1A1MEN1THRB
SCHEMBL17894087 0.71 HDAC4 (0.44) KMT2APOLBALDH1A1MEN1APEX1
SCHEMBL9688805 0.71 ALDH1A1 (0.44) KMT2APOLBALDH1A1MEN1THRB
SCHEMBL9689991 0.71 ALDH1A1 (0.44) KMT2APOLBALDH1A1MEN1THRB
SCHEMBL9689750 0.71 ALDH1A1 (0.44) KMT2APOLBALDH1A1MEN1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240228487-A1 FUSED HETEROCYCLIC COMPOUND AND APPLICATION THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND APPLICATION THEREOF ZHEJIANG UNIVERSITY (CN) 2024-07-11 US disclosed
EP-4306522-A1 FUSED RING HETEROCYCLIC COMPOUND AND APPLICATION THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AND APPLICATION THEREOF Zhejiang University (CN) 2024-01-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240228487-A1 FUSED HETEROCYCLIC COMPOUND AND APPLICATION THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND APPLICATION THEREOF TRPM2, TRPM8, TRPM7 KMT2A 2286/4885POLB 4645/4885ALDH1A1 2555/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.